This course will begin with a brief review of ocular surface disease, including definition, risk factors, and how to identify/diagnose. Followed by background on blepharitis (Demodex), chalazion, and hordeolum. Emphasis will be placed on both 1) modern in-office therapeutic options (i.e. MBE, Thermal Expression, IPL, Amniotic Membrane) as well as 2) updated pharmaceutical options (ie immunomodulators, recently FDA-approved ophthalmic therapies, and new drugs in the pipeline). We will also discuss managing blepharitis with glaucoma patients. If time allows, we will cover patient cases.

Almost 1600 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• No more baby shampoo lid scrubs?!?!?!? His explanation made sense. Thank you!!!

• Thank you for your lecture highlighting the treatments of ocular surface disease.

• Glad to hear about upcoming treatments and strategies for tackling one thing at a time. Thanks.

• Great summary of newest glaucoma and dry eye treatments.

• An excellent presentation. The speaker was concise and prepared in his presentation.

• Knowledgeable speak! Great web resources.

• Great lecture, some very interesting info and great resources! Thank you!

• Very informative and current info. Thank you!

• He is very impressive and so knowledgeable! Thank you again!

• Learned things I didn't know I would learn!

Speaker: Dr. Vin Dang

Moderator: Dr. Ariel Cerenzie

COPE ID: 97329-TD

Category: Trt/Mngmnt Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Tarsus Pharmaceuticals for providing an educational grant to support this event.